tiprankstipranks

Helen K. Ellias Insider Profile

4 Followers
Helen K. Ellias, Director at SAB Biotherapeutics, holds 2.86M shares in SAB Biotherapeutics (Ticker: SABS).
tipranks
Helen K. Ellias

Helen K. Ellias
SAB Biotherapeutics (SABS)
Director

Not Ranked
Helen K. Ellias has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$9M
100.00%
A breakdown of Helen K. Ellias's holdings

Insider Roles

SAB Biotherapeutics
(SABS)
Director
Roles that Helen K. Ellias holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Helen K. Ellias

Helen K. Ellias's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
SAB Biotherapeutics
Nov 28, 2023
Director
Uninformative Buy
2.57M
$8.94M
Helen K. Ellias has not reported any informative transactions for SABS, therefore, performance cannot be measured.
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Nov 28, 2023
Uninformative Buy
$2.57M
-
$0.90
List of latest transactions for each holding click on a transaction to see Helen K. Ellias's performance on stock

Helen K. Ellias insider profile FAQ

What is the percentage of profitable transactions made by Helen K. Ellias?
The percentage of profitable transactions made by Helen K. Ellias is ―.
    What is the average return per transaction made by Helen K. Ellias?
    The average return per transaction made by Helen K. Ellias is ―.
      What stocks does Helen K. Ellias hold?
      Helen K. Ellias holds: SABS stocks.
        What was Helen K. Ellias’s latest transaction?
        Helen K. Ellias latest transaction was an Uninformative Buy of $2.57M.
          What was Helen K. Ellias's most profitable transaction?
          Helen K. Ellias’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Helen K. Ellias's role in SAB Biotherapeutics?
            Helen K. Ellias's role in SAB Biotherapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.